tirzepatide and retatrutide together Weight loss with retatrutide1, tirazepatide2, semaglutide3 compared Switching From Tirzepatide to Retatrutide
Description
Retrieved July 10th, 2024 from Viking Therapeutics (n.d.)
Molecular and cellular responses of islets during perturbations of glucose homeostasis determined by in situ hybridization histochemistry
In SURMOUNT-2, SURMOUNT-3 and SURMOUNT-4 were used TZP doses of 10 and 15 mg and all three doses, including the 5-mg dose, were used in SURMOUNT-1
There are also possible side effects such as nausea, vomiting, diarrhea and constipation
2022;38(6): e3548
No commitment
